Nkarta raises ~$225.2M in underwritten offering of stock and pre-funded warrants

Nkarta, Inc.

Offering of 21,010,000 shares at $10.00 and pre-funded warrants for 3,000,031 shares at $9.9999.
Net proceeds of ~$225.2M after underwriting discounts and estimated expenses.
Proceeds to fund NKX019 clinical development and internal manufacturing buildout.
Pre-funded warrants exercisable immediately at $0.0001 per share, with 19.99% ownership cap.
Underwriting agreement with Leerink Partners and Cowen and Company, LLC, dated March 25, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.